PCI-32765 (Ibrutinib)

SKU: C-1248-5mg

Quantity (mg):

5 mg

Product Options

Quantity

$57.99

Catalog#: C-1248

Targets: BTK

Synonym: PCI32765; PCI-32765; PCI 32765; Ibrutinib; Imbruvica

Chemical Name/IUPAC:(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one

Technical Data

Product Name: PCI-32765 (Ibrutinib)

Chemical Formula: C25H24N6O2

Molecular Weight: 440.49

CAS#: 936563-96-1

Appearance: Solid powder

Purity: > 99% by HPLC

Solubility: Soluble in DMSO

Storage: Room temperature for months, or -20ºC for 3 years

Description
PCI-32765 (Ibrutinib) is an orally bioavailable small-molecule inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. BTK inhibitor PCI-32765 binds to and inhibits BTK activity, preventing B-cell activation and B-cell-mediated signaling and inhibiting the growth of malignant B cells that overexpress BTK.

PCI-32765 (Ibrutinib)

Related products

A-1210477

ABT-199 (Venectoclax)

ABT-263 (Navitoclax)

ABT-737